Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative desmopressin to reduce blood loss during septorhinoplasty
IRCT20190325043107N69Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Apr 2024
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of desmopressin in Not applicable, sponsored by Tabriz University of Medical Sciences. Primary endpoint: Intraoperative blood loss. Started Apr 2024; status: completed.
02
Drugs
desmopressin
03
Conditions
Not applicable
Beyond the preview
Go deeper on IRCT20190325043107N69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190325043107N69.